Sun Pharma announces FDA tentative approval for generic Cymbalta

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Sun Pharmaceutical Industries Ltd. announced US FDA has granted its subsidiary a tentative approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Cymbalta®, duloxetine hydrochloride delayed-release capsules. These generic duloxetine hydrochloride delayed-release capsules, 20 mg (base), 30 mg (base), and 60 mg (base) are indicated in the treatment of Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD) and Diabetic Peripheral Neuropathic Pain

Investments in the U.S. of Over $70bn Announced by Merck

Pharmaceutical Manufacturing Fire Safety Through Skilled Workforce Training

LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood

US Tariffs on Pharma Exports from Singapore Deferred

UK Exchequer Wants More Pharma Investment Coming in Britain

Future-proof vial filling – How flexibility Along the Line Defines Success

How Smart Digital Strategies are Leading the Way in Pharmaceutical Manufacturing

Rethinking Real-World Data Partnerships: How to Fill Gaps Without Starting Over

Energy efficiency in pure steam generation: How small adjustments can lead…

Pharmacovigilance Systems Gaining Higher Ground with AI

Just Announced: AI in Drug Discovery 2026 Agenda

Ensera Launches as New Brand Identity for SteriPack

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by…

Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a…

Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI

Sun Pharma announces FDA tentative approval for generic Cymbalta

Investments in the U.S. of Over $70bn Announced by Merck

Pharmaceutical Manufacturing Fire Safety Through Skilled Workforce Training

LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood

US Tariffs on Pharma Exports from Singapore Deferred

Investments in the U.S. of Over...

Pharmaceutical Manufacturing Fire Safety Through Skilled...

LTS Grows U.S. Footprint by Buying...

US Tariffs on Pharma Exports from...

UK Exchequer Wants More Pharma Investment...

Just Announced: AI in Drug Discovery...

Investments in the U.S. of Over $70bn Announced by Merck

Pharmaceutical Manufacturing Fire Safety Through Skilled Workforce Training

LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood

US Tariffs on Pharma Exports from Singapore Deferred

About us

latest updates

System

subscribe us

Resources

Subscribe

Investments in the U.S. of Over $70bn Announced by Merck

Pharmaceutical Manufacturing Fire Safety Through Skilled Workforce Training